Search hospitals > Ohio > Toledo
University of Toledo
Claim this profileToledo, Ohio 43614
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
207 reported clinical trials
8 medical researchers
Summary
University of Toledo is a medical facility located in Toledo, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. University of Toledo is involved with conducting 207 clinical trials across 353 conditions. There are 8 research doctors associated with this hospital, such as Roland Skeel, MD, Mouhammad Jumaa, MD, Firas G. Petros, and Imran Ali.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Roland Skeel, MDUniversity of Toledo9 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
10 reported clinical trials
18 drugs studied
Mouhammad Jumaa, MDProMedica Toledo Hospital3 years of reported clinical research
Studies Stroke
Studies Ischemic Stroke
5 reported clinical trials
7 drugs studied
Firas G. PetrosUniversity of Toledo3 years of reported clinical research
Studies Prostate Cancer
Studies Bladder Cancer
4 reported clinical trials
22 drugs studied
Imran AliUniversity of Toledo2 years of reported clinical research
Studies Syndrome
Studies Dravet Syndrome
3 reported clinical trials
2 drugs studied
Clinical Trials running at University of Toledo
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Bladder Cancer
Cancer
Pancreatic Cancer
Renal Cell Carcinoma
Lennox Gastaut Syndrome
Syndrome
ALK Gene Rearrangement
Crizotinib
for Non-Small Cell Lung Cancer
This study is evaluating whether a drug called crizotinib may help treat patients with non-small cell lung cancer.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This study is evaluating whether the addition of a drug to chemotherapy may help treat non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
IO102-IO103 + Pembrolizumab
for Cancer
A Phase II Multi-Arm (basket) Trial Investigating the Safety and Efficacy of IO102-IO103 in Combination with pembrolizumab, as First-line Treatment for Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of Head or Neck (SCCHN), or Metastatic Urothelial Bladder Cancer (mUBC)
Recruiting1 award Phase 24 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Toledo?
University of Toledo is a medical facility located in Toledo, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. University of Toledo is involved with conducting 207 clinical trials across 353 conditions. There are 8 research doctors associated with this hospital, such as Roland Skeel, MD, Mouhammad Jumaa, MD, Firas G. Petros, and Imran Ali.